| Identification of a CD4-binding-site antibody to HIV that evolved near-pan neutralization breadth J Huang, BH Kang, E Ishida, T Zhou, T Griesman, Z Sheng, F Wu, ... Immunity 45 (5), 1108-1121, 2016 | 345 | 2016 |
| Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques L Xu, A Pegu, E Rao, N Doria-Rose, J Beninga, K McKee, DM Lord, ... Science 358 (6359), 85-90, 2017 | 309 | 2017 |
| Vaccine-induced antibodies that neutralize group 1 and group 2 influenza A viruses MG Joyce, AK Wheatley, PV Thomas, GY Chuang, C Soto, RT Bailer, ... Cell 166 (3), 609-623, 2016 | 302 | 2016 |
| Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1 K Xu, P Acharya, R Kong, C Cheng, GY Chuang, K Liu, MK Louder, ... Nature medicine 24 (6), 857-867, 2018 | 275 | 2018 |
| New member of the V1V2-directed CAP256-VRC26 lineage that shows increased breadth and exceptional potency NA Doria-Rose, JN Bhiman, RS Roark, CA Schramm, J Gorman, ... Journal of virology 90 (1), 76-91, 2016 | 243 | 2016 |
| Bispecific antibodies targeting different epitopes on the HIV-1 envelope exhibit broad and potent neutralization M Asokan, RS Rudicell, M Louder, K McKee, S O'dell, G Stewart-Jones, ... Journal of virology 89 (24), 12501-12512, 2015 | 106 | 2015 |
| Activation and lysis of human CD4 cells latently infected with HIV-1 A Pegu, M Asokan, L Wu, K Wang, J Hataye, JP Casazza, X Guo, W Shi, ... Nature communications 6 (1), 8447, 2015 | 102 | 2015 |
| Virus-like particles identify an HIV V1V2 apex-binding neutralizing antibody that lacks a protruding loop EM Cale, J Gorman, NA Radakovich, ET Crooks, K Osawa, T Tong, J Li, ... Immunity 46 (5), 777-791. e10, 2017 | 84 | 2017 |
| Longitudinal analysis reveals early development of three MPER-directed neutralizing antibody lineages from an HIV-1-infected individual SJ Krebs, YD Kwon, CA Schramm, WH Law, G Donofrio, KH Zhou, S Gift, ... Immunity 50 (3), 677-691. e13, 2019 | 80 | 2019 |
| Optimization of the solubility of HIV-1-neutralizing antibody 10E8 through somatic variation and structure-based design YD Kwon, IS Georgiev, G Ofek, B Zhang, M Asokan, RT Bailer, A Bao, ... Journal of virology 90 (13), 5899-5914, 2016 | 77 | 2016 |
| Multiple NF-κB sites in HIV-1 subtype C long terminal repeat confer superior magnitude of transcription and thereby the enhanced viral predominance M Bachu, S Yalla, M Asokan, A Verma, U Neogi, S Sharma, RV Murali, ... Journal of Biological Chemistry 287 (53), 44714-44735, 2012 | 76 | 2012 |
| Surface-matrix screening identifies semi-specific interactions that improve potency of a near pan-reactive HIV-1-neutralizing antibody YD Kwon, GY Chuang, B Zhang, RT Bailer, NA Doria-Rose, TS Gindin, ... Cell reports 22 (7), 1798-1809, 2018 | 59 | 2018 |
| Fc-mediated effector function contributes to the in vivo antiviral effect of an HIV neutralizing antibody M Asokan, J Dias, C Liu, A Maximova, K Ernste, A Pegu, K McKee, W Shi, ... Proceedings of the National Academy of Sciences 117 (31), 18754-18763, 2020 | 58 | 2020 |
| Structure and recognition of a novel HIV-1 gp120-gp41 interface antibody that caused MPER exposure through viral escape CK Wibmer, J Gorman, G Ozorowski, JN Bhiman, DJ Sheward, DH Elliott, ... PLoS pathogens 13 (1), e1006074, 2017 | 44 | 2017 |
| Enhancing durability of CIS43 monoclonal antibody by Fc mutation or AAV delivery for malaria prevention NK Kisalu, LD Pereira, K Ernste, Y Flores-Garcia, AH Idris, M Asokan, ... JCI insight 6 (3), 2021 | 31 | 2021 |
| Improvement of antibody functionality by structure-guided paratope engraftment Q Liu, YT Lai, P Zhang, MK Louder, A Pegu, R Rawi, M Asokan, X Chen, ... Nature Communications 10 (1), 721, 2019 | 30 | 2019 |
| Exceptional molecular and coreceptor-requirement properties of molecular clones isolated from an Human Immunodeficiency Virus Type-1 subtype C infection PK Dash, NB Siddappa, A Mangaiarkarasi, AV Mahendarkar, P Roshan, ... Retrovirology 5, 1-22, 2008 | 28 | 2008 |
| Program NCS MG Joyce, AK Wheatley, PV Thomas, GY Chuang, C Soto, RT Bailer, ... Mullikin JC, Subbarao K, Douek DC, Graham BS, Koup RA, Ledgerwood JE …, 2016 | 20 | 2016 |
| Potent anti-viral activity of a trispecific HIV neutralizing antibody in SHIV-infected monkeys A Pegu, L Xu, ME DeMouth, G Fabozzi, K March, CG Almasri, MD Cully, ... Cell reports 38 (1), 2022 | 19 | 2022 |
| A matrix of structure-based designs yields improved VRC01-class antibodies for HIV-1 therapy and prevention YD Kwon, M Asokan, J Gorman, B Zhang, Q Liu, MK Louder, BC Lin, ... MAbs 13 (1), 1946918, 2021 | 11 | 2021 |
